I have actually been working most of the weekend arranging the conference call, etc.
I was able to speak with Dr. Strayer Friday evening and we discussed some of the issues. I then phoned Dr. Carter and suggested that we do this conference call because I feel that the unknown is worse than the known. I am hopeful that the issues will be discussed in detail and everyone will have a good understanding of the problem areas. I believe that some of the deficiencies will be easily resolved. I cant go into detail now, but hopefully during the conference call it will be very clear to everyone. Many of the issues are due to the long regulatory history of Ampligen at the FDA, as stated in the press release.